| 000 | 01819 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250512112849.0 | ||
| 264 | 0 | _c19730118 | |
| 008 | 197301s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/0005-2744(72)90106-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAkopyan, Z I | |
| 245 | 0 | 0 |
_aInduced appearance of adenylate-deaminating activity in highly purified bovine liver mitochondrial monoamine oxidase. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cNov 1972 |
||
| 300 |
_a44-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdenine Nucleotides |
| 650 | 0 | 4 | _aAdenosine Diphosphate |
| 650 | 0 | 4 | _aAdenosine Monophosphate |
| 650 | 0 | 4 | _aAdenosine Triphosphate |
| 650 | 0 | 4 |
_aAminohydrolases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCattle |
| 650 | 0 | 4 | _aDeamination |
| 650 | 0 | 4 |
_aErgocalciferols _xadverse effects |
| 650 | 0 | 4 |
_aEthylmaleimide _xpharmacology |
| 650 | 0 | 4 |
_aHydroxylamines _xpharmacology |
| 650 | 0 | 4 | _aInosine Nucleotides |
| 650 | 0 | 4 |
_aIsoniazid _xpharmacology |
| 650 | 0 | 4 | _aLipid Metabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMitochondria, Liver _xenzymology |
| 650 | 0 | 4 |
_aMonoamine Oxidase _xmetabolism |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aOleic Acids _xpharmacology |
| 650 | 0 | 4 | _aOxidation-Reduction |
| 650 | 0 | 4 |
_aPeroxides _xmetabolism |
| 650 | 0 | 4 | _aRabbits |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aSpectrophotometry, Ultraviolet |
| 650 | 0 | 4 |
_aSulfhydryl Compounds _xanalysis |
| 700 | 1 | _aKulygina, A A | |
| 700 | 1 | _aTerzeman, I I | |
| 700 | 1 | _aGorkin, V Z | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 289 _gno. 1 _gp. 44-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0005-2744(72)90106-4 _zAvailable from publisher's website |
| 999 |
_c4543185 _d4543185 |
||